あすか製薬(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証1部 | 医薬品 | 4514/E00929 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2018/12/07 | 日証協 | 313,825株 | -15.99% | 69,370株 | +85.04% | 346,599株 | -10.85% | 110,909株 | +269.83% |
2018/11/30 | 日証協 | 373,559株 | -8.25% | 37,490株 | -58.92% | 388,798株 | -10.29% | 29,989株 | -46.54% |
2018/11/22 | 日証協 | 407,158株 | +1.01% | 91,265株 | -70.06% | 433,398株 | -7.43% | 56,100株 | -59.78% |
2018/11/16 | 日証協 | 403,082株 | +40.64% | 304,847株 | +7.49% | 468,179株 | +42.94% | 139,500株 | -43.01% |
2018/11/09 | 日証協 | 286,609株 | +8.42% | 283,616株 | +30.92% | 327,528株 | -7.43% | 244,800株 | +277.2% |
2018/11/02 | 日証協 | 264,344株 | +5.87% | 216,637株 | -21.2% | 353,828株 | +2.25% | 64,900株 | -6.62% |
2018/10/26 | 日証協 | 249,691株 | +7.94% | 274,929株 | +73.11% | 346,028株 | -0.37% | 69,500株 | -7% |
2018/10/19 | 日証協 | 231,322株 | +40.4% | 158,820株 | +82.4% | 347,328株 | +13.1% | 74,730株 | +60.8% |
2018/10/12 | 日証協 | 164,761株 | +31.74% | 87,071株 | +18.67% | 307,098株 | +22.1% | 46,475株 | -14.82% |
2018/10/05 | 日証協 | 125,061株 | -8.12% | 73,372株 | -31.31% | 251,508株 | -6.06% | 54,558株 | +5.55% |
2018/09/28 | 日証協 | 136,111株 | -0.62% | 106,811株 | +69.64% | 267,740株 | -1.08% | 51,689株 | +129.84% |
2018/09/21 | 日証協 | 136,965株 | -16.69% | 62,965株 | +74.49% | 270,674株 | +3.67% | 22,489株 | -47.11% |
2018/09/14 | 日証協 | 164,400株 | -6.84% | 36,086株 | -29.79% | 261,095株 | +3.41% | 42,521株 | +5.96% |
2018/09/07 | 日証協 | 176,479株 | +5.37% | 51,400株 | -53.1% | 252,488株 | +1.45% | 40,128株 | +94.78% |
2018/08/31 | 日証協 | 167,479株 | +39.46% | 109,600株 | +55.33% | 248,874株 | +2.54% | 20,602株 | -55.01% |
2018/08/24 | 日証協 | 120,090株 | -25.5% | 70,558株 | -30.56% | 242,719株 | -4.52% | 45,789株 | +6.23% |
2018/08/17 | 日証協 | 161,185株 | +7.91% | 101,606株 | -24.6% | 254,206株 | -3.91% | 43,102株 | -56.2% |
2018/08/10 | 日証協 | 149,372株 | +0.88% | 134,751株 | -26.56% | 264,561株 | -2.67% | 98,414株 | +60.81% |
2018/08/03 | 日証協 | 148,072株 | -4.83% | 183,493株 | +16.89% | 271,805株 | +12.59% | 61,200株 | -21.33% |
※株式分割は考慮していませんのでご注意ください。
Page Top